Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up.
Luzzago S, Catellani M, Di Trapani E, Cozzi G, Mistretta FA, Bianchi R, Pricolo P, Conti A, Ancona E, Piacentini N, Alessi S, Renne G, Ferro M, Matei DV, Musi G, Jereczek-Fossa BA, Petralia G, de Cobelli O. Luzzago S, et al. Among authors: catellani m. Prostate Cancer Prostatic Dis. 2020 Mar;23(1):195. doi: 10.1038/s41391-019-0198-2. Prostate Cancer Prostatic Dis. 2020. PMID: 31836874 Free article.
Robot-assisted Partial Nephrectomy: 5-yr Oncological Outcomes at a Single European Tertiary Cancer Center.
Vartolomei MD, Matei DV, Renne G, Tringali VM, Crisan N, Musi G, Mistretta FA, Russo A, Cozzi G, Cordima G, Luzzago S, Cioffi A, Di Trapani E, Catellani M, Delor M, Bottero D, Imbimbo C, Mirone V, Ferro M, de Cobelli O. Vartolomei MD, et al. Among authors: catellani m. Eur Urol Focus. 2019 Jul;5(4):636-641. doi: 10.1016/j.euf.2017.10.005. Epub 2017 Oct 27. Eur Urol Focus. 2019. PMID: 29111154
Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol.
Luzzago S, Musi G, Catellani M, Russo A, Di Trapani E, Mistretta FA, Bianchi R, Cozzi G, Conti A, Pricolo P, Ferro M, Matei DV, Mirone V, Petralia G, de Cobelli O. Luzzago S, et al. Among authors: catellani m. Urol Int. 2018;101(1):56-64. doi: 10.1159/000488772. Epub 2018 May 7. Urol Int. 2018. PMID: 29734177
Long-term oncologic and functional outcomes after robot-assisted partial nephrectomy in elderly patients.
Vartolomei MD, Matei DV, Renne G, Tringali VM, Crișan N, Musi G, Mistretta FA, Russo A, Conti A, Cozzi G, Luzzago S, Catellani M, Cioffi A, Cordima G, Bianchi R, Di Trapani E, Serino A, Delor M, Bianco R, Bottero D, Ferro M, De Cobelli O. Vartolomei MD, et al. Among authors: catellani m. Minerva Urol Nefrol. 2019 Feb;71(1):31-37. doi: 10.23736/S0393-2249.18.03006-0. Epub 2018 Sep 19. Minerva Urol Nefrol. 2019. PMID: 30230293 Free article.
Neutrophil, Platelets, and Eosinophil to Lymphocyte Ratios Predict Gleason Score Upgrading in Low-Risk Prostate Cancer Patients.
Ferro M, Musi G, Serino A, Cozzi G, Mistretta FA, Costa B, Bianchi R, Cordima G, Luzzago S, Di Trapani E, Tagliabue E, Vartolomei MD, Terracciano D, Cassatella MC, Salvatici M, Conti A, Sandri MT, Cioffi A, Turetti M, Catellani M, Bottero D, Matei DV, Mirone V, de Cobelli O. Ferro M, et al. Among authors: catellani m. Urol Int. 2019;102(1):43-50. doi: 10.1159/000494259. Epub 2018 Nov 8. Urol Int. 2019. PMID: 30408799
Multiparametric Magnetic Resonance Imaging Second Opinion May Reduce the Number of Unnecessary Prostate Biopsies: Time to Improve Radiologists' Training Program?
Luzzago S, Petralia G, Musi G, Catellani M, Alessi S, Di Trapani E, Mistretta FA, Serino A, Conti A, Pricolo P, Nazzani S, Mirone V, Matei DV, Montanari E, de Cobelli O. Luzzago S, et al. Among authors: catellani m. Clin Genitourin Cancer. 2019 Apr;17(2):88-96. doi: 10.1016/j.clgc.2018.10.006. Epub 2018 Oct 23. Clin Genitourin Cancer. 2019. PMID: 30527286
Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up.
Luzzago S, Catellani M, Di Trapani E, Cozzi G, Mistretta FA, Bianchi R, Pricolo P, Conti A, Ancona E, Piacentini N, Alessi S, Renne G, Ferro M, Matei DV, Musi G, Jereczek-Fossa BA, Petralia G, de Cobelli O. Luzzago S, et al. Among authors: catellani m. Prostate Cancer Prostatic Dis. 2020 Mar;23(1):94-101. doi: 10.1038/s41391-019-0160-3. Epub 2019 Jun 27. Prostate Cancer Prostatic Dis. 2020. PMID: 31249386
Safety and feasibility of thullium laser transurethral resection of prostate for the treatment of benign prostatic enlargement in overweight patients.
Carmignani L, Clementi MC, Signorini C, Motta G, Nazzani S, Palmisano F, De Lorenzis E, Catellani M, Mistretta AF, Conti A, Tringali V, Costa MB, Vizziello D. Carmignani L, et al. Among authors: catellani m. Asian J Urol. 2019 Jul;6(3):270-274. doi: 10.1016/j.ajur.2018.05.004. Epub 2018 May 17. Asian J Urol. 2019. PMID: 31297319 Free PMC article.
A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings.
Luzzago S, de Cobelli O, Cozzi G, Peveri G, Bagnardi V, Catellani M, Di Trapani E, Mistretta FA, Pricolo P, Conti A, Alessi S, Marvaso G, Ferro M, Matei DV, Renne G, Jereczek-Fossa BA, Petralia G, Musi G. Luzzago S, et al. Among authors: catellani m. BJU Int. 2020 Jul;126(1):104-113. doi: 10.1111/bju.15048. Epub 2020 Apr 1. BJU Int. 2020. PMID: 32150328 Free article.
82 results